Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market - Global Outlook and Forecast 2021-2027

Code: RW00014647478
Market Monitor Global
Dec-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global, including the following market information:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market was valued at 5330.8 million in 2020 and is projected to reach US$ 6884.5 million by 2027, at a CAGR of 6.6% during the forecast period.
Publisher has surveyed the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Type, 2020 (%)
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Application, 2020 (%)
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Overall Market Size
2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size: 2021 VS 2027
2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in Global Market
3.2 Top Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Ranked by Revenue
3.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Markets, 2021 & 2027
4.1.2 PCR
4.1.3 In-situ Hybridization
4.1.4 Immunohistochemistry
4.1.5 Sequencing
4.1.6 Others
4.2 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
4.2.2 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
4.2.3 By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Neurological Disorders
5.1.4 Cardiovascular Disease
5.1.5 Immunological Disorders
5.1.6 Others
5.2 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
5.2.2 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
5.2.3 By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2021 & 2027
6.2 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2021
6.2.2 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2022-2027
6.2.3 By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
6.3.2 US Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.3.3 Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.3.4 Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
6.4.2 Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.3 France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.4 U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.5 Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.6 Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.7 Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.4.8 Benelux Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
6.5.2 China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.5.3 Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.5.4 South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.5.5 Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.5.6 India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
6.6.2 Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.6.3 Argentina Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027
6.7.2 Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.7.3 Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.7.4 Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
6.7.5 UAE Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, 2016-2027
7 Players Profiles
7.1 Qiagen NV
7.1.1 Qiagen NV Corporate Summary
7.1.2 Qiagen NV Business Overview
7.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.1.4 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.1.5 Qiagen NV Key News
7.2 GE Healthcare
7.2.1 GE Healthcare Corporate Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.2.4 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.2.5 GE Healthcare Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.3.4 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.3.5 Agilent Technologies Key News
7.4 F Hoffman La Roche
7.4.1 F Hoffman La Roche Corporate Summary
7.4.2 F Hoffman La Roche Business Overview
7.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.4.4 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.4.5 F Hoffman La Roche Key News
7.5 Foundation Medicine
7.5.1 Foundation Medicine Corporate Summary
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.5.4 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.5.5 Foundation Medicine Key News
7.6 Thermo Fisher Scientific Inc.
7.6.1 Thermo Fisher Scientific Inc. Corporate Summary
7.6.2 Thermo Fisher Scientific Inc. Business Overview
7.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.6.4 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.6.5 Thermo Fisher Scientific Inc. Key News
7.7 Leica Biosystems Nussloch GmBH
7.7.1 Leica Biosystems Nussloch GmBH Corporate Summary
7.7.2 Leica Biosystems Nussloch GmBH Business Overview
7.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.4.4 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.7.5 Leica Biosystems Nussloch GmBH Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Major Product Offerings
7.8.4 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Opportunities & Trends in Global Market
Table 2. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers in Global Market
Table 3. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints in Global Market
Table 4. Key Players of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global Market
Table 5. Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Type
Table 9. List of Global Tier 1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2022-2027
Table 30. Qiagen NV Corporate Summary
Table 31. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 32. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 35. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 38. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 39. F Hoffman La Roche Corporate Summary
Table 40. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 41. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 42. Foundation Medicine Corporate Summary
Table 43. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 44. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 45. Thermo Fisher Scientific Inc. Corporate Summary
Table 46. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 47. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 48. Leica Biosystems Nussloch GmBH Corporate Summary
Table 49. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 50. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offerings
Table 53. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Segment by Type
Figure 2. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Segment by Application
Figure 3. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2020
Figure 8. By Type - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 12. US Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 16. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 17. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 24. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 28. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 30. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share, 2016-2027
Figure 33. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, (US$, Mn), 2016-2027
Figure 37. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE